302 related articles for article (PubMed ID: 10695894)
1. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group.
Iannaccone ST; Russman BS; Browne RH; Buncher CR; White M; Samaha FJ
J Child Neurol; 2000 Feb; 15(2):97-101. PubMed ID: 10695894
[TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema.
Russman BS; Iannacone ST; Buncher CR; Samaha FJ; White M; Perkins B; Zimmerman L; Smith C; Burhans K; Barker L
J Child Neurol; 1992 Oct; 7(4):347-53. PubMed ID: 1469240
[TBL] [Abstract][Full Text] [Related]
3. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
Febrer A; Rodriguez N; Alias L; Tizzano E
J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
[TBL] [Abstract][Full Text] [Related]
4. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
[TBL] [Abstract][Full Text] [Related]
5. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
Salort-Campana E; Quijano-Roy S
Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
[TBL] [Abstract][Full Text] [Related]
7. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
Nelson L; Owens H; Hynan LS; Iannaccone ST;
Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
[TBL] [Abstract][Full Text] [Related]
8. Muscle fatigue in spinal muscular atrophy.
Iannaccone ST; White M; Browne R; Russman B; Buncher R; Samaha FJ
J Child Neurol; 1997 Aug; 12(5):321-6. PubMed ID: 9378900
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
[TBL] [Abstract][Full Text] [Related]
10. Werdnig-Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance.
Boylan KB; Cornblath DR
Ann Neurol; 1992 Sep; 32(3):404-7. PubMed ID: 1416812
[TBL] [Abstract][Full Text] [Related]
11. Function changes in spinal muscular atrophy II and III. The DCN/SMA Group.
Russman BS; Buncher CR; White M; Samaha FJ; Iannaccone ST
Neurology; 1996 Oct; 47(4):973-6. PubMed ID: 8857729
[TBL] [Abstract][Full Text] [Related]
12. [An autopsy case with lower motor neuron disease showing a transient-appearance of anti-GM1 antibody and an improvement of conduction block after gamma-globulin administration].
Kikuchi H; Kawano Y; Dohura K; Kawamura T; Taniwaki T; Yamada T; Kato M; Iwaki T; Kira J
No To Shinkei; 1999 May; 51(5):455-64. PubMed ID: 10396755
[TBL] [Abstract][Full Text] [Related]
13. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease].
Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R
Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861
[No Abstract] [Full Text] [Related]
14. [Clinical, electrophysiological and molecular study of 26 chilean patients with spinal muscular atrophy].
Castiglioni C; Levicán J; Rodillo E; Garmendia MA; Díaz A; Pizarro L; Contreras L
Rev Med Chil; 2011 Feb; 139(2):197-204. PubMed ID: 21773657
[TBL] [Abstract][Full Text] [Related]
15. Spinal muscular atrophy: the natural course of disease.
Russman BS; Melchreit R; Drennan JC
Muscle Nerve; 1983; 6(3):179-81. PubMed ID: 6855803
[TBL] [Abstract][Full Text] [Related]
16. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.
Van den Berg-Vos RM; Visser J; Kalmijn S; Fischer K; de Visser M; de Jong V; de Haan RJ; Franssen H; Wokke JH; Van den Berg LH
Arch Neurol; 2009 Jun; 66(6):751-7. PubMed ID: 19506135
[TBL] [Abstract][Full Text] [Related]
17. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal muscular spinal atrophy: a case report].
Pavone P; Velardita M; Trigilia T; Luca G; Lucenti C; Romeo G; Falsaperla R
Pediatr Med Chir; 2004; 26(2):139-41. PubMed ID: 15700740
[TBL] [Abstract][Full Text] [Related]
19. Spinal muscular atrophy: clinical classification and disease heterogeneity.
Russman BS
J Child Neurol; 2007 Aug; 22(8):946-51. PubMed ID: 17761648
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3.
Khirani S; Colella M; Caldarelli V; Aubertin G; Boulé M; Forin V; Ramirez A; Fauroux B
Eur J Paediatr Neurol; 2013 Nov; 17(6):552-60. PubMed ID: 23672834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]